BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8769690)

  • 1. Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry.
    Horowitz MM; Rowlings PA; Passweg JR
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S5-6. PubMed ID: 8769690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
    Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
    Speiser DE; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1997 Jun; 19(12):1197-203. PubMed ID: 9208113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of allogeneic bone marrow transplantation: a report from the International Bone Marrow Transplant Registry.
    Bortin MM; Gale RP
    Clin Transpl; 1986; ():17-28. PubMed ID: 3154398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry.
    Bortin MM; Horowitz MM; Gale RP
    Nat Immun Cell Growth Regul; 1988; 7(5-6):334-50. PubMed ID: 3065641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
    Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report from the International Bone Marrow Transplant Registry.
    Rowlings PA; Horowitz MM; Rimm AA; Sobocinski KA; Zhang MJ; Bortin MM
    Clin Transpl; 1992; ():83-90. PubMed ID: 1306725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry.
    Bone Marrow Transplant; 1989 May; 4(3):221-8. PubMed ID: 2659107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects.
    Thall PF; Champlin RE; Andersson BS
    Bone Marrow Transplant; 2004 Jun; 33(12):1191-9. PubMed ID: 15122310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries.
    Silberman G; Crosse MG; Peterson EA; Weston RC; Horowitz MM; Appelbaum FR; Cheson BD
    N Engl J Med; 1994 Oct; 331(16):1063-7. PubMed ID: 8090167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A simple model of the optimal time for allogenic bone marrow transplantation in chronic granulocytic leukemia].
    Popović S; Pejin D; Uzurov V
    Med Pregl; 1997; 50(3-4):100-2. PubMed ID: 9229678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
    Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S7-9. PubMed ID: 8769691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
    Morariu-Zamfir R; Rocha V; Devergie A; Socié G; Ribaud P; Esperou H; Parquet N; Guardiola P; Dal Cortivo L; Bittencourt H; Garnier F; Traineau R; Marolleau JP; Chevret S; Gluckman E
    Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
    Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.
    Passweg JR; Rowlings PA; Armitage JO; Gale RP; Pelz CJ; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM
    Clin Transpl; 1995; ():117-27. PubMed ID: 8794259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Millot F; Esperou H; Bordigoni P; Dalle JH; Michallet M; Michel G; Bourhis JL; Kuenz M; Blaise D; Garban F; Plouvier E; Rome A; Guilhot J; Guilhot F
    Bone Marrow Transplant; 2003 Nov; 32(10):993-9. PubMed ID: 14595387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia.
    Drobyski WR; Pelz C; Kabler-Babbitt C; Hessner M; Baxter-Lowe LA; Keever-Taylor CA
    Biol Blood Marrow Transplant; 1998; 4(1):3-12. PubMed ID: 9701386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.